Abstract 3328: Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
Aleix Prat(Breast Cancer Research Foundation), Charles M. Perou(Segeberger Kliniken), Xiaping He(University of North Carolina at Chapel Hill), J. Chuck Harrell(Virginia Commonwealth University), Melissa A. Troester(University of North Carolina at Chapel Hill), Erick Roman(University of North Carolina at Chapel Hill), Olga Karginova(University of Illinois Chicago), Lisa M. Bixby(University of North Carolina at Chapel Hill), Cheng Fan(University of North Carolina at Chapel Hill), Joel S. Parker(University of North Carolina at Chapel Hill)
Cited by 13
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k